Continuous Glucose Monitoring MarketSize, Share & Industry Analysis, 2026-2034By ComponentBy Product TypeBy Sensor Wear DurationBy Sensing TechnologyBy ApplicationBy Age GroupBy Connectivity and IntegrationBy End UserBy Distribution ChannelBy Reimbursement Status
Full title & scope — all 10 axes with their segments
Continuous Glucose Monitoring Market Size, Share & Industry Analysis, By Component (Sensors, Transmitters, Receivers and Readers, Software and Data Platforms, Insertion and Accessories), By Product Type (Real-Time CGM, Intermittently Scanned CGM, Professional CGM, Over-the-Counter CGM), By Sensor Wear Duration (Up to 7 Days, 8 to 10 Days, 11 to 15 Days, Beyond 15 Days), By Sensing Technology (Minimally Invasive Enzymatic Electrochemical, Implantable Fluorescence-Based, Non-Invasive, Microneedle-Based), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Prediabetes and Metabolic Health, Hospital Glycemic Management), By Age Group (Pediatric, Adult, Geriatric), By Connectivity and Integration (Standalone CGM, Integrated with Insulin Pumps, Integrated with Smart Pens, Open-Source and Third-Party Integrated), By End User (Home Care Settings, Hospitals, Clinics and Endocrinology Centers, Ambulatory Surgical and Long-Term Care Facilities, Research and Clinical Trial Organizations), By Distribution Channel (Retail Pharmacies, Online Pharmacies and E-Commerce, Direct-to-Consumer / Manufacturer Direct, Durable Medical Equipment Suppliers, Hospital Pharmacies), By Reimbursement Status (Public Insurance Reimbursed, Private Insurance Reimbursed, Out-of-Pocket), and Regional Forecast, 2026-2034
Segment definitions and share of revenue by product, animal, end user and region.
Segmentation Analysis
10 axesBy Component
5- 01Sensors
- 02Transmitters
- 03Receivers and Readers
- 04Software and Data Platforms
- 05Insertion and Accessories
By Product Type
4- 01Real-Time CGM (rtCGM)
- 02Intermittently Scanned CGM (isCGM / Flash)
- 03Professional CGM
- 04Over-the-Counter CGM
By Sensor Wear Duration
4- 01Up to 7 Days
- 028 to 10 Days
- 0311 to 15 Days
- 04Beyond 15 Days
By Sensing Technology
4- 01Minimally Invasive Enzymatic Electrochemical
- 02Implantable Fluorescence-Based
- 03Non-Invasive
- 04Microneedle-Based
By Application
5- 01Type 1 Diabetes
- 02Type 2 Diabetes
- 03Gestational Diabetes
- 04Prediabetes and Metabolic Health
- 05Hospital Glycemic Management
By Age Group
3- 01Pediatric (0 to 17 Years)
- 02Adult (18 to 64 Years)
- 03Geriatric (65 Years and Above)
By Connectivity and Integration
4- 01Standalone CGM
- 02Integrated with Insulin Pumps
- 03Integrated with Smart Pens
- 04Open-Source and Third-Party Integrated
By End User
5- 01Home Care Settings
- 02Hospitals
- 03Clinics and Endocrinology Centers
- 04Ambulatory Surgical and Long-Term Care Facilities
- 05Research and Clinical Trial Organizations
By Distribution Channel
5- 01Retail Pharmacies
- 02Online Pharmacies and E-Commerce
- 03Direct-to-Consumer / Manufacturer Direct
- 04Durable Medical Equipment Suppliers
- 05Hospital Pharmacies
By Reimbursement Status
3- 01Public Insurance Reimbursed
- 02Private Insurance Reimbursed
- 03Out-of-Pocket
Segment categories shown for scope reference. See the Summary tab for revenue share by Component. Full segment-by-segment detail across every axis is available in the sample and full report.
Questions This Report Answers
6 questionsWhat is the market size and growth rate, globally and by region?
How is the market segmented, and which segments lead?
Which regions and countries are covered, and how do they compare?
What are the key drivers, restraints, opportunities and challenges?
Who are the leading companies operating in this market?
What trends are expected to shape the market through the forecast period?
Frequently Asked Questions
01What is the Continuous Glucose Monitoring Market projected to reach?
USD 36 USD Billion by 2034, CAGR 11.47%
02What years does this report cover?
Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.
03Which regions are covered?
North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
04Which region accounted for the largest market share?
North America leads with 45% of global revenue through 2034.
05Which segment leads the market?
Sensors is the largest line by Component, at 52% of revenue in 2025.
06Who are the key companies profiled?
Dexcom, Inc., Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd, Senseonics Holdings, Inc., Insulet Corporation, Tandem Diabetes Care, Inc., Ascensia Diabetes Care Holdings AG, LifeScan, Inc., Sinocare Inc., Medtrum Technologies Inc., Roche Diabetes Care GmbH, i-SENS, Inc., Glucotrack, Inc., Biolinq, Inc., Embecta Corp., Terumo Corporation, Yuwell Medical (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.), Microtech Medical (Hangzhou) Co., Ltd., Ypsomed Holding AG, Diabeloop SA, Trividia Health, Inc., Nemaura Medical Inc., Dexcom Europe / Eversense partner Ascensia, Meiqi / Shenzhen Silicon Biotech Co., Ltd., Glucomen / A. Menarini Diagnostics S.r.l., Sibionics (Shenzhen Sibionics Technology Co., Ltd.). Full profiles are part of the paid report.
07Can the segmentation be customized?
Yes. Custom data cuts by geography, segment, or competitor set are available on request.
Why choose CDI
Need this report shaped around your question?
The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.
Most licences include 30–60 hours of customization at no extra cost. See what each licence includes
Additional Companies
Add competitors, suppliers or the peer set you benchmark against to the companies already covered.
Deeper Competitive View
Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.
Extra Segment Splits
Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.
Application Focus
Narrow the analysis to the specific use cases and end users your team actually sells into.
Different Time Frame
Move the base year, or widen the historical and forecast windows the study is built on.
Country-Level Detail
Go below region level into the individual countries that matter to you, rather than the standard geography split.